Preventative Med Flashcards

1
Q

protocol for infant if mother is positive for HepB surface antigen

A
  • Vaccine and immunoglobulin w/in 12 hrs of birth
  • 2nd dose of vaccine at 1-2 mo
  • 3rd dose of vaccine at 6 mo

NB: if status of mother unknown, give vaccine at birth and test mother; if found to be pos give Ig w/in 7 days

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Hib vaccine - effectiveness against

  • invasive disease
  • otitis media
A

invasive disease: 95-100%

otitis media: none (usually caused by non-typable)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Hib vaccine timing

A

AFTER 6 weeks

early than 6 wks - immune tolerance to antigen may be induced

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

pregnant woman who has not had chicken pox and has not had the varicella vaccine - her? household contacts?

A
  • vaccinate mother after delivery

- household contacts do not need to delay (if mother is immunocompetent)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

infection following varicella vaccine

A

1% of people vaccinated

does not appear to be contageious

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

homosexual male who has had all the “typical childhood vaccines” - what vaccine is indicated

A

Hep A

Behavioral risk categories:

  • more than one sexual partner in last 6 months
  • seeking tx for another sexually transmitted disease
  • current or recent injection-drug user
  • MSM

Occupational risk categories:

  • health care
  • public safety

Medical risk categories:

  • chronic liver disease
  • HIV
  • end-stage renal disease
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

rubella vaccine and pregnancy

A
  • contraindicated if pregnant or planning to be pregnant in the next 4 weeks
  • vaccinate postpartum
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

influenza vaccine recomendations (children)

A
  • annually for children 6mo and older
  • minimum age for live vaccine is 2 y/o
  • 2 doses at least 4 wks apart for children between 6mo and 8yrs who are receiving vaccine for the first time or who were vaccinated for the first time last year but only received 1 dose
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

PCV7 (7 valent pneumococcal) recommendation for children under 5

A
  • healthy 24-59 m/o who have not completed primary immunization –> give 1 dose PCV7
  • if they received less than 3 doses of PCV7 during primary immunization, give 2 doses at least 8 wks apart
  • usual schedule: 2,4,6,12,15 months
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

HPV quadrivalent vaccine

A
  • females 9-26
  • best before sexually active
  • ok in brest feeding, h/o abnormal pap, immunocompromised
  • not recommended during pregnancy
  • males 9-26
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Tdap in pts over 65

A
  • pts over 65 who have close contact with an infant less that 12 m/o regardless of interval of most recent Td vaccine
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

influenza live vaccine (intranasal)

A

healthy adults younger than 50

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Year considered immune to:

  • MMR
  • Varicella
A
  • MMR: 1957

- Varicella: 1980

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

varicella zoster vaccine

A
  • adults 60 yrs or older regardless of h/o prior episode(s) of zoster

(NOT currently approved for persons younger than 60)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

screening for lipids in men w/o other risk factors

  • age?
  • what are the risk factors (examples)
A

men - 35

RFs:

  • diabetic pt
  • FamHx of heart disease by age 50
  • (others)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

(? lung cancer screening)

A

?

17
Q

colon cancer screening (age)

A

either:

50 y/o or 10 yrs before cancer was found in family member (whichever is EARLIER) to age 75

18
Q

age to begin routine mammogram screening w/ no fam hx

A
  • 50 y/o
  • prior to age 50, should be individualized
  • 50-75 y/o every 2 yrs
19
Q

USPSTF and AAFP recommendation re: self breast exams (#19)

A

both recommend AGAINST BSE for women at average risk for breast cancer

20
Q

AAFP recomendation re: prostate cancer screenings

A
  • evidence insufficient to recommend for or against routine prostate cancer screening in men younger than 75 yrs
21
Q

Cervical cancer screening begins at what age

A

21 or 3 yrs after sexually active

22
Q

discontinuation of paps

A

USPSTF
- age 65

American Cancer Society
- age 70
or
- has had 3 or more documented normal, technically satisfactory pap tests, and has had no abnormal pap tests in the last 10 yrs

23
Q

referral for genetic counseling for breast cancer

A

must meet specific high-risk criteria

non-Ashkenazi Jewish women

  • 2 first degree relatives, one who was dx before 50
  • 2 or more first or second degree relatives with breast cancer
  • first degree relative w/ bilateral breast cancer
  • 2 or more first or second degree with ovarian cancer
  • first or second degree with both breast and ovarian cancer
  • male relative with breast cancer

Aschkenazi Jewish women
- any first or 2 second degree relatives on same side of family w/ breast or ovarian cancer

24
Q

Surgeries:

  • low risk
  • moderate risk
  • low risk
A

low ( 5%; high anticipated blood loss)

  • aortic
  • peripheral vascular
25
Q

pre-op cardiac evaluation

A

(see flow sheet and #29/30)

26
Q

MCC of death while traveling

A

heart disease

2nd is accidents - 25%

27
Q

high BP on combination oral contraceptives… next steps?

A

discontinue oral contraceptives and BP should return to normal w/in 3 months

NB: both E and P can increase BP; risk increases with age

28
Q

MC side effect cited as the reason for discontinuing COCs

A

irregular bleeding
(common in the first 3 months and generally diminishes over time)

other SEs:

  • androgenic effects (hair growth, male pattern baldness, nausea,
  • estrogenic effects (nausea, breast tenderness, fluid retention)
29
Q

Type of testing most appropriate for identifying the diagnosis for a child with multiple malformations with unknown etiology

A
cytogenetic analysis
(study of chromosome size, number, structure)

NB: direct DNA indicated when looking for a specific genetic disease